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https://doi.org/10.1016/j.cell.2021.05.033SUMMARYThe capping of mRNA and the proofreading play essential roles in SARS-CoV-2 replication and transcription.
Here, we present the cryo-EM structure of the SARS-CoV-2 replication-transcription complex (RTC) in a form
identified as Cap(0)-RTC, which couples a co-transcriptional capping complex (CCC) composed of nsp12
NiRAN, nsp9, the bifunctional nsp14 possessing an N-terminal exoribonuclease (ExoN) and a C-terminal
N7-methyltransferase (N7-MTase), and nsp10 as a cofactor of nsp14. Nsp9 and nsp12 NiRAN recruit
nsp10/nsp14 into the Cap(0)-RTC, forming the N7-CCC to yield cap(0) (7MeGpppA) at 50 end of pre-mRNA.
A dimeric form of Cap(0)-RTC observed by cryo-EM suggests an in trans backtracking mechanism for
nsp14 ExoN to facilitate proofreading of the RNA in concert with polymerase nsp12. These results not only
provide a structural basis for understanding co-transcriptional modification of SARS-CoV-2 mRNA but
also shed light on how replication fidelity in SARS-CoV-2 is maintained.INTRODUCTION
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
is the causative agent of coronavirus disease 2019 (COVID-19).
The genome of SARS-CoV-2 encodes 16 non-structural proteins
(nsp1–nsp16) to assemble the replication-transcription complex
(RTC) that plays key roles in the replication of genome-length
viral RNAs and in the transcription of viral mRNAs (Wu et al.,
2020). CoV mRNAs bear a 50 cap(1) structure (7MeGpppA20OMe)
that plays an essential role in the life cycle of the virus (Daffis
et al., 2010). In SARS-CoV-2 RTC, co-transcriptional capping
of mRNA occurs after elongation initiation by four sequential ac-
tions in the co-transcriptional capping complex(s) (CCC) (Yan
et al., 2021). The first and the second capping actions that
sequentially generate the 50-diphosphate end (ppA) and the
cap core (GpppA) at the 50 end of the nascent pre-mRNA by
nsp13 and the nidovirus RdRp-associated nucleotidyltransfer-
ase (NiRAN) domain in nsp12. In the subsequent capping3474 Cell 184, 3474–3485, June 24, 2021 ª 2021 Elsevier Inc.actions, an N7-methyltransferase (N7-MTase) in nsp14 methyl-
ates the first guanine of GpppA at the N7-position to produce
the cap(0) (7MeGpppA), being the substrate for the final capping
action facilitated by a 20-O-methyltransferase (20-O-MTase) in
nsp16 to yield the mature mRNA (Bouvet et al., 2010; Chen
et al., 2009, 2011; Decroly et al., 2008; Ivanov et al., 2004; Ivanov
and Ziebuhr, 2004; Yan et al., 2021).
CoV nsp14 is a bifunctional enzyme bearing an N-terminal
exonuclease (ExoN) domain that has been implicated in proof-
reading to maintain replication fidelity (Eckerle et al., 2007,
2010; Minskaia et al., 2006) and a C-terminal N7-MTase domain
that catalyzes the thirdmRNA capping action to yield the cap(0)(-
Chen et al., 2009). The C-terminal N7-MTase adopts an atypical
MTase fold with a conserved DxG S-adenosylmethionine (SAM)
binding motif (Case et al., 2016; Ferron et al., 2018; Ma et al.,
2015). Compared with the canonical MTase fold, an insertion
of a three-stranded b sheet between the canonical MTase b5/
b6 strands is observed in CoV nsp14. A similar insertion is also
ll
Articleobserved in Vaccinia virus N7-MTase(Grimm et al., 2019). The
binding site of SAM is in the space between the loops connecting
strands b20-b30 and b30-b40 and is adjacent to the GpppA binding
site (Ma et al., 2015). The N-terminal ExoN is a member of the
DEDDh exonuclease superfamily and possesses a 30-50 exonu-
clease activity proposed to correct errors in replication by
removing mis-incorporated nucleotides from the 30 end of the
nascent RNA strand (Ferron et al., 2018; Munster et al., 2020;
Ogando et al., 2019). A feature of this exonuclease is that it
has a proofreading mechanism tomaintain the replication fidelity
of the ~29.7 kb CoV genome. Nsp14 ExoN has also been shown
to play roles in sub-genomic mRNA recombination and primary
viral RNA synthesis (Gribble et al., 2021; Ogando et al., 2020).
The proofreading is suggested to be a factor that impacts the
inhibitory efficacy of nucleotide analog inhibitors (Robson
et al., 2020). Escape from nsp14 ExoN proofreading is sug-
gested to be associated with enhanced inhibitory efficacy of
b-D-N4-hydroxycytidine (NHC; EIDD-1931) and derivatives
against SARS-CoV-2 that has resistancemutations to remdesivir
(Robson et al., 2020; Sheahan et al., 2020). Furthermore, the
function of nsp14 requires its association with a virus-encoded
cofactor nsp10 (Ma et al., 2015). Nsp10 exclusively binds with
and confers structural integrity and stability to nsp14 ExoN and
thus enhances the activity of nsp14 ExoN over 35-fold, preferring
to use double-stranded RNA (dsRNA) with a 30 mis-matched
substrate that mimics an erroneous replication product (Bouvet
et al., 2010, 2012). But nsp10 does not impact the structure
and the activity of nsp14 N7-MTase (Bouvet et al., 2010; Ma
et al., 2015).
In previous studies, the architectures of the central RTC (C-
RTC) composed by nsp12 and cofactors nsp7 and nsp8 and
the elongation RTC (E-RTC) composed by C-RTC and helicase
(nsp13) have been revealed, and the structure of Cap(1)0-RTC
formed by E-RTC with a single-strand RNA binding protein
nsp9 reveals an intermediate state toward mRNA capping
(Chen et al., 2020; Gao et al., 2020; Wang et al., 2020; Yan
et al., 2020, 2021). Interactions between nsp14 (both N7-MTase
and ExoN) and the nsp12-nsp7-nsp8 complex (Subissi et al.,
2014) indicate its involvement in the assembly of the RTC. How-
ever, the structural details as to how the nsp10/nsp14 complex
assembles remain elusive, impeding our understanding of the
mechanisms of the function of nsp14 in mRNA capping and
proofreading. To dissect these mechanisms, we generated a
complex [identified as Cap(0)-RTC] formed by Cap(1)0-RTC
(i.e., nsp7-nsp82-nsp9-nsp12-nsp132-RNA) and nsp10/nsp14
and determined its cryoelectron microscopy (cryo-EM) structure
to 3.78 and 3.35 Å resolution in both monomeric and dimeric
forms. The structure not only reveals the architecture of the
capping machinery coupled to RTC that achieves the capping
actions decorating the 50 end of pre-mRNA but also provides a
structural basis to understand the polymerase activity and the
mechanism by which nsp14 ExoN is used for proofreading.
RESULTS
Preparation and structure determination of Cap(0)-RTC
The recombinant proteins used to assemble Cap(0)-RTC were
expressed in E. coli cells and purified (Figure S1A). In a nativeelectrophoretic mobility shift assay (EMSA), the addition of
nsp10/nsp14 to Cap(1)0-RTC resulted in a smeared upper-
shifted band, indicating the formation of a potential complex,
possibly in multiple forms (Figure S1B). With this sample, we
collected a cryo-EM dataset containing 507 micrograph movies
to determine whether a complex had formed. In total, 12% of the
particles could be identified as belonging to Cap(1)0-RTC with
additional density, while the other particles had no clear features
(Figure S2; Table S1). A reconstruction using 5,985 particles
gave a density map at 7.9 Å. Although the resolution was limited
due to the small amount of particles, a convincing model could
be built. We proposed that additional density adjacent to nsp9
and nsp12 NiRAN likely corresponded to nsp10/nsp14 (Fig-
ure S3). We therefore hypothesized the association of nsp9/
nsp10/nsp14 may mediate the coupling of nsp10/nsp14 into
Cap(0)-RTC, but the small number of interactions between
them may result in a low number of complexes being formed
or there being inherent flexibility when they associate.
A previous study has shown that the proteolytic processing of
nsp9-nsp10 in coronaviruses is not required for virus prolifera-
tion and fitness, indicating a natural connection between
nsp10 and nsp9 exists in the CoV life cycle (Deming et al.,
2007). A strategy where a linker is inserted to fuse two polypep-
tide components into one protein is an approach that can be
used to improve the prospects of forming a homogeneous sam-
ple where two individual subunits may only weakly associate
(Shabek et al., 2018; Soon et al., 2012; Wang et al., 2017). Using
this approach, we fused the C terminus of nsp9 with the N termi-
nus of nsp10 by using the natural polypeptide linker in the viral
polyprotein connecting nsp9 and nsp10 and expressed this re-
combinant nsp9-nsp10 fusion protein together with nsp14 (Fig-
ures S1A and 1C). This nsp9-nsp10 fusion protein forms a stable
complex with nsp14 as occurs for nsp10 alone (Figure 1C). This
purified nsp9-nsp10/nsp14 complex was thus subsequently
used to assemble Cap(0)-RTC by incubating with E-RTC [i.e.,
Cap(1)0-RTC excludes nsp9].
After collecting and processing 12,704 cryo-EM micrograph
movies, 5major classes were identified: 9.0% belong to amono-
meric Cap(0)-RTC [hereafter named as mCap(0)-RTC], 15.3%
belongs to a previously unobserved large particle representing
a dimeric form of Cap(0)-RTC [hereafter named as dCap(0)-
RTC], and 48.4% belongs to E-RTC, and another 2 classes
belong to small fragments (Figure S4). The classes representing
mCap(0)-RTC (with 29,941 particles) and dCap(0)-RTC (with
47,981 particles) were reconstructed to resolutions of 3.35 and
3.78 Å, respectively (Figure S4; Table S1). The high-quality den-
sity clearly shows the position of nsp10/nsp14 adjacent to nsp9
and nsp12 NiRAN with a resolution of 3.0–4.5 Å in this region
(Figures S3 and S5A). The local resolution for the density of
nsp7-nsp82-nsp9-nsp12 ranges from 3.0 to 4.0 Å. The local res-
olution for nsp13-2, which anchors the unpaired 50 extension of
the RNA template, is significantly optimized compared to previ-
ously reported RTC structures (Yan et al., 2020, 2021).
Architecture of Cap(0)-RTC
In mCap(0)-RTC, one nsp10/nsp14 complex associates with
Cap(1)0-RTC composed of one nsp7, two nsp8, one nsp9,
one nsp12, two nsp13, and a paired template-primer RNA, beingCell 184, 3474–3485, June 24, 2021 3475
Figure 1. Overall structure
(A) Domain organization of each component in Cap(0)-RTC. The color scheme for each component in Cap(0)-RTC is generally similar to that used previously (Gao
et al., 2020; Yan et al., 2020, 2021), with modifications. Nsp7, deep purple; nsp8-1, gray; nsp8-2, green cyan; nsp9, purple blue; nsp10, slate; nsp12 NiRAN,
yellow; nsp12 Interface, orange; nsp12 fingers, blue; nsp12 palm, red; nsp12 thumb, forest; nsp13 ZBD, light green; nsp13 S, salmon; nsp13 1B, violet; nsp13 1A,
sand; nsp13 2A, hot pink; nsp14 ExoN, pale green; nsp14 N7-MTase, brown.
(B and C) Structure of mCap(0)-RTC (B) and dCap(0)-RTC (C) in cartoon diagrams (top panels) and the cryo-EM densities (bottom panels) are shown in three
perpendicular views. The 2-fold axis is indicated by ellipses (left and right panel) or an arrow (middle panel). The dashed lines roughly indicate the boundary of two
Cap(0)-RTC protomers in dCap(0)-RTC (C).
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Figure 2. Architecture of N7-CCC
(A) N7-CCC in Cap(0)-RTC protomer is shown as colored cartoons from a side view (top panel) and a top view (bottom panel). For a clear representation, the
components of EC in Cap(0)-RTC protomer is shown as a white molecular surface, whereas the primer-template RNAs are shown as cartoon diagrams.
(B–D) Inter-molecular interactions in N7-CCC. The polypeptides of nsp9, nsp10, and nsp12 NiRAN are shown as colored cartoons; nsp14 is covered by a colored
surface. The interacting residues of nsp14 to contact with nsp9 and nsp12 are highlighted by the color of their interacting partners with labels (B and C). The inter-
molecular interactions of nsp14with nsp9/nsp12 are shown in detail (C, right panel). The interacting residues of nsp14 to contact with nsp10 are highlighted by the
color as in nsp10 (D).
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Articlemediated by the contact of nsp9 and nsp12 NiRAN with nsp14
(Figures 1A and 1B). The architecture of Cap(1)0-RTC is gener-
ally similar to a previously reported structure (Yan et al., 2021).
Nsp9 and nsp12 NiRAN make contacts with nsp14 ExoN to sta-
bilize the association of nsp10/nsp14 in Cap(0)-RTC but do not
interact with nsp14 N7-MTase. According to a previous defini-
tion, nsp13-1 refers to the helicase molecule that does not
bind with RNA, while nsp13-2 refers to the helicase molecule
that binds the 50 extension of template (Yan et al., 2020, 2021).
In dCap(0)-RTC, two Cap(0)-RTC protomers are oriented by a
2-fold axis to form a dimer (Figures 1A and 1C; Figure S5B).
Nsp12 NiRAN and the palm of two Cap(0)-RTC protomers face
each other and locate in the center of dCap(0)-RTC, while four
nsp13s are at the two distal ends of the dimer. The binding of
nsp9 and nsp12 NiRAN with nsp14 ExoN is similar in both
mCap(0)-RTC and dCap(0)-RTC. Nsp14 N7-MTase, which is
distant from other components in one Cap(0)-RTC protomer,
closely contacts with the nsp13-2 zinc binding domain (ZBD)0
and nsp12 thumb0 in another Cap(0)-RTC protomer, playing a
key role in dimer formation. Moreover, nsp13-2, which anchors
the unpaired 50 extension of template RNA, shows a significant
conformational change in dCap(0)-RTC, compared to nsp13-1
in dCap(0)-RTC, nsp13-2 in mCap(0)-RTC and other reported
CoV helicase structures (discussed below).Structure of N7-CCC
In Cap(0)-RTC, nsp12 NiRAN, nsp9, nsp10, and nsp14 form a
CCC catalyzing the methylation of the first guanine at the N7-
position to produce the cap(0) (7MeGpppA)(Chen et al., 2009)
(hereafter referred to as N7-CCC), being boundaried by
nsp12 NiRAN and nsp9 from the elongation complex (EC)
composed of nsp7, nsp8, nsp12 Interface/Thumb/Palm/Fin-
gers, and nsp13 (Figure 2A).
In N7-CCC, the rod-shaped nsp10/nsp14 complex vertically
inserts into and is stabilized by a canyon region formed by
nsp9 and nsp12 NiRAN (Figures 2A and 2B). Nsp9 and nsp10
flank nsp14 ExoN from two sides to stabilize the assembly.
Nsp14 N7-MTase protrudes distal from the interface of nsp14
with nsp9 and nsp12 NiRAN. Although nsp10 is fused with
nsp9 in Cap(0)-RTC, nsp10 does not contact with nsp9 except
for the fusion residues, indicating again that the nsp9-nsp10
fusion does not affect the assembly of RTC. The catalytic center
of nsp14 ExoN composed by residues D90/E92/E191/D273/
H268 directly faces the central b sheet of nsp9. Moreover, the
catalytic center of nsp14 N7-MTase is localized on the opposite
side of nsp12 NiRAN.
Nsp14 ExoN contributes themajority of interactions for the as-
sociation of nsp10/nsp14 into Cap(0)-RTC with a contacting sur-
face of 2,396 Å2 (Figures 2C and 2D; Table S2). The side-chainCell 184, 3474–3485, June 24, 2021 3477
Figure 3. Inter-protomer interactions
(A) One Cap(0)-RTC protomer is shown as a cartoon diagram and the another is shown as a molecular surface. The inter-protomer interacting regions are
indicated by the dashed frames.
(B) Key residues on the inter-protomer interface. The Cap(0)-RTC protomer is colored as in Figure 1. The interacting residues are highlighted by a white color on
the surface with labels.
(C and D) The interaction details in regions 1 and 2. The interacting residues are displayed as colored sticks. Dashed lines indicate contact distances less
than 3.5 Å.
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Articlenitrogen atoms of nsp9R111 form hydrogen bonds with the imid-
azole group of nsp14H95 and the carbonyl of nsp14T103 and a
side-chain nitrogen of nsp14K13 forms a hydrogen bond with
nsp12Q224. The side-chain nitrogen atoms of nsp14R98 contact
with nsp12Q81 and nsp12E84. The overall structure of nsp10/
nsp14 complex in Cap(0)-RTC shows strong similarities with
that reported in the crystal structures of nsp10/nsp14 complex
(Ma et al., 2015) (Figure S6A). The residues of nsp14 interacting
with nsp10 includes nsp14T5, nsp14D10, nsp14T21, nsp14T25,
nsp14H26, nsp14C39, nsp14D41, nsp14K47, nsp14Y51, nsp14F60,
nsp14T127, nsp14N130, and nsp14T131, which are consistent with
the reported crystal structure (Ma et al., 2015). Sequence com-
parison shows that these key interacting residues are highly
conserved in SARS-CoV-2, SARS-CoV, MERS-CoV, and
RaTG13 (Figure S6B), suggesting a common mechanism for
N7-CCC formation in CoVs. The N terminus of nsp9 inserts
into the catalytic center of nsp12 NiRAN, which is similar to
that observed in Cap(1)0-RTC (Yan et al., 2021), but the bound
GDP-Mg2+ in the nsp12 NiRAN catalytic center is missing. It is
noteworthy that a recent study suggests that nsp9 is a substrate
for nsp12 NiRAN NMPylation, but in another study it is debated
that nsp7 is the substrate (Conti et al., 2020; Slanina et al., 2021).
We hypothesize that the post-translation modification of nsp9 by
nsp12 NiRAN might play a role in complex formation.3478 Cell 184, 3474–3485, June 24, 2021Inter-protomer interaction of Cap(0)-RTC
The inter-protomer interactions of dCap(0)-RTC are contributed
by nsp7, nsp8-2, nsp12 NiRAN/thumb/palm/fingers, nsp13-2
ZBD, nsp14 ExoN, and N7-MTase at five separate regions (Fig-
ure 3A; Table S3).
In region 1, nsp14V460, nsp14Y465, nsp14L479, and nsp14V483 of
nsp14 N7-MTase in protomer A forms a hydrophobic interface
with the residues nsp13-2I79, nsp13-2F81, and nsp13-2F90 of
nsp13-2 ZBD0 in protomer B (Figure 3B). Three hydrogen bonds
are observed between nsp14D464, nsp14S470, and nsp14Y517 of
nsp14 N7-MTase in protomer A and nsp8-2Y12 (in nsp8-2
0),
nsp12S904 (in nsp12 thumb
0), and nsp13-2N86 (in nsp13-2 ZBD0)
in protomer B (Figure 3C). Notably, the loop region of nsp14
N7-MTase spanning residues nsp14S454- nsp14D464, which
cannot be traced in the reported crystal structure, is well defined
with unambiguous cryo-EM density (Figure S6A, right panel). We
reason that the contact of this region with nsp13-2 ZBD0 in the
other Cap(0)-RTC protomer helps to stabilize its conformation.
In region 2, the residues of nsp14 N7-MTase (including
nsp14L406, nsp14K433, nsp14Q441, and nsp14I502) and ExoN (resi-
due nsp14D172) inprotomerAconstitute asetof inter-molecular in-
teractionswith the residuesof nsp12 thumb0 (including nsp12Q886,
nsp12R889, nsp12E917, and nsp12E919) and nsp12 fingers
0
(including nsp12K426 and nsp12E431) in protomer B (Figure 3D). In
ll
Articleregion 3, although nsp12 NiRAN and palm are located in the cen-
tral parts of dCap(0)-RTC and face each other, only a single bond
formed by nsp12I106 in protomer A and nsp12N158 in protomer B is
observed (Figure 3A). It is noteworthy that the inter-protomer
interface are located on the opposite side of the SAMandGpppA
bindingsitesof nsp14N7-MTase, allowing full solventexposureof
the nsp14 N7-MTase catalytic site in dCap(0)-RTC.
Nsp13-2 1B has a significant structural rearrangement
In Cap(0)-RTCs, two nsp13s are located on a plane formed by
nsp12 and two nsp8s, which are in the similar position as they
are in E-RTC and Cap(1)0-RTC (Figures 1B and 1C). In
mCap(0)-RTC, the folding of the two nsp13s is virtually identical.
In dCap(0)-RTC, nsp13-1, which does not bind template RNA
andwas shown to play a role in the stimulation of the helicase ac-
tivity of another nsp13 (Yan et al., 2020), exhibit structural similar-
ity in dCap(0)-RTC and E-RTCwith a root-mean-square deviation
(RMSD) of 0.74 Å for all Ca atoms (Figure 4A, left panel). In
contrast, nsp13-2, which binds to the 50 extension of the unpaired
template RNA, exhibits a remarkable conformational change
within its 1B domain (Figure 4A, right panel). Nsp13-2 1B in
dCap(0)-RTCexhibits a ~90 rotation toward nsp13-2ZBDalong-
side the C terminus of nsp13-2 S and is approximately 25 Å from
nsp13-2 2A (Figure 4A, right panel). In contrast, the 1B domain in
all other reported structures of CoV nsp13 (either crystal or cryo-
EM structures) is adjacent to the 2A domain. This previously
unobserved position of nsp13-2 1B not only causes variation of
the inter-helicase interactions but also results in significant differ-
ences in helicase-RNA interaction (Figures 4B–4L).
The movement of nsp13-2 1B results in variations of
inter-molecular interactions
In mCap(0)-RTC, the loop region spanning residues nsp13-2T2
14-nsp13-2V221ofnsp13-21Bmakescontactswith the long loop re-
gion connecting nsp13-1 1B and 1A (Figures 4B and 4F). Similar
inter-helicase interactions can be also found in the structures of
E-RTC (Yan et al., 2020) and Cap(1)0-RTC (Yan et al., 2021) (Fig-
ures 4D, 4E, 4H, and 4I). Following the movement of nsp13-2 1B
in dCap(0)-RTC, the contacts between the 1B domains of the two
nsp13 in RTC is completely abolished (Figures 4C and 4G). More-
over, the loop region spanning residues nsp13-2G203-nsp13-2A208
of nsp13-2 1B in dCap(0)-RTC contacts nsp13-1 ZBD and nsp8-
1 (Figure 4J). In this region, the side chain of nsp13-2D204 hydrogen
bonds with Nh1 of nsp8-2R75 in the central long helix of nsp8-2, and
the carbonyl oxygen of nsp13-2G206 contacts with the side chain of
nsp13-1Q11 in the ZBD. Previous studies on SARS-CoV-2 RTCs
have shown that nsp8-1 participates in the assembly of C-RTC to
arm the paired template-product RNA and in the recruitment of
nsp13-1 into RTCs (Wang et al., 2020; Yan et al., 2020, 2021).
The structural feature presented in dCap(0)-RTC suggests that
nsp8-1 also contacts with nsp13-2 with a conformational change
of the 1B domain, presumably to play a role in the regulation of
the function of nsp13-2.
Variations in the binding of nsp13-2 with 50 extension of
the template RNA
The movement of nsp13-2 1B is associated with the variations in
RNA interactions. Although we used the same template andprimer RNAs in our investigations on RTCs in this and previous
studies (Yan et al., 2020, 2021), the unpaired 50 extension of
the template RNA is not observed in the mCap(0)-RTC like in
Cap(1)0-RTC. We therefore only compared the binding of
nsp13-2 with the 50 extension of template RNA in dCap(0)-RTC
and in E-RTC (Figures 4K and 4L).
In E-RTC, tU+7 to tU+12 in the unpaired 50 extension of tem-
plate RNA is anchored in a RNA-binding channel clamped by
nsp13-2 1A, 2A and 1B domains (Yan et al., 2020) (Figures 4H
and 4L). The positively charged side chains of nsp13-2N177 and
nsp13-2R178 of nsp13-2 1B bond with tA+10 and tA+11, and
the imidazole group of nsp13-2H230 packs with the base of tA+8
(Figure 4L, right panel). In dCap(0)-RTC, the RNA-binding chan-
nel is disappears following the downward movement of nsp13-2
1B. As a result, the cryo-EM density shows there is no binding of
RNA to nsp13-2 1A and 2A domains. However, the unambiguous
cryo-EM density supports a model of template RNA continu-
ously extended from tC+4 to tA+9 (Figures 4G and 4K). The
side chains of nsp13-2N177 and nsp13-2R178 of nsp13-2 1B con-
tact with tU+7 and tA+8 of the unpaired 50 extension of template
RNA, but nsp13-2H230 does not interact with template RNA (Fig-
ure 4K). The nucleotides of tU+3 to tG+6 in E-RTC cannot be
traced in this cryo-EM density map (Yan et al., 2020) but have
good density in dCap(0)-RTC (Figure 4G). We reasoned that
the contact of nsp13-2N177 and nsp13-2R178 with RNA in
dCap(0)-RTC helps to stabilize the conformation of these four
nucleotides. It is noteworthy that the densities of the first 17 nu-
cleotides cannot be visualized in dCap(0)-RTC, though there is
sufficient length of RNA to reach nsp13-2 1A/2A, suggesting
1B, but not 1A and 2A, plays the most important role in RNA
binding of helicase.
Comparison of the helicase orientations in RTCs
The orientations of helicases show distinct features in different
RTCs (Figures 4B-4E). In E-RTC, ZBDs of two nsp13 are placed
on the long helical structure of nsp8-1 and nsp8-2 (Yan et al.,
2020) (Figure 4D). Although the folding of two helicases are iden-
tical in Cap(1)0-RTC, the orientation of nsp13-2 changes, with
nsp13-2 ZBD inserting deeply into the second minor groove of
the paired template-primer RNA (Yan et al., 2021) (Figure 4E),
reasoning E-RTC is in a ‘‘Elongation’’ state and Cap(1)0-RTC
is in a ‘‘Suspending’’ state.
In mCap(0)-RTC, nsp13-2 has a similar orientation as in
Cap(1)0-RTC and inserts its ZBD into the paired template-
primer RNA (Figure 4B), suggesting mCap(0)-RTC is also in a
‘‘Suspending’’ state. In contrast, despite nsp13-2 1B having a
large conformational change in dCap(0)-RTC, nsp13-2 ZBD
stays in a state as it appears in E-RTC. Both ZBD and 1B with
conformational change of nsp13-2 makes no interaction with
the paired template-primer RNA (Figure 4C), suggesting the
movement of RNA is possible in dCap(0)-RTC as in E-RTC,
rather in mCap(0)-RTC.
DISCUSSION
The coupling of capping machinery(s) in SARS-CoV-2 RTC is
essential for virus mRNA maturation and gene transcription. In
previous studies, the assembly of RTCs for RNA synthesis andCell 184, 3474–3485, June 24, 2021 3479
Figure 4. Conformational change of nsp13-2 1B
(A) Comparison of nsp13 in E-RTC and dCap(0)-RTC. The polypeptides of nsp13-1 and nsp13-2 in E-RTC are colored light blue, whereas these in dCap(0)-RTC
are shown as the color scheme in Figure 1.
(B–E) Comparison of orientations of nsp13 inmCap(0)-RTC (B), dCap(0)-RTC (C), E-RTC (D), and Cap(1)0-RTC (E). The helicases are shown as colored surfaces,
while nsp7, nsp8, and nsp12 are shown as white surfaces. Template and primer RNAs are shown as colored cartoons. Four structures are aligned with the
guidance of nsp12 and shown in the same orientation. The red dashed lines indicate the positions of the edge of nsp8-2 to compare the locations of subunits.
(F–I) Enlarged views of nsp13-2 1B in RTCs. The polypeptides in RTCs are shown as colored cartoons with the color scheme as in Figure 1. Nsp13-2 1B is covered
by cryo-EM densities (gray mesh); the unpaired 50 extension of template RNA bound with nsp13-2 in dCap(0)-RTC (G) and E-RTC (H) are covered by cryo-EM
densities as red meshes.
(J) Interaction of nsp13-2 1B with nsp13-1 ZBD and nsp8-1 in dCap(0)-RTC. The interacting residues are displayed as colored sticks.
(K and L) Interaction of nsp13-2 1Bwith the unpaired 50 extension of template RNA in dCap(0)-RTC (K) and E-RTC (L). Key interacting residues andRNAmolecules
are shown as colored sticks.
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Figure 5. A potential transferring path for pre-mRNA in capping
(A) An overall view of N7-CCC. N7-CCC is shown as colored cartoon and the
EC is covered by white molecular surface. Nsp9, nsp10, nsp12 NiRAN, nsp14
ExoN, and nsp14 N7-MTase are colored purple, blue, yellow, pale green, and
brown, respectively. A GpppA and a SAM bound to nsp14 N7-MTase in the
crystal structure (Ma et al., 2015) (PDB code: 5C8S) are shown as spheres with
colors as following: C atoms for SAM, cyan; C atoms for GpppA, yellow; O
atoms, red; N atoms, blue; P atoms, gold. GDP-Mg2+ bound in the catalytic
center of nsp12 NiRAN in Cap(1)0-RTC (Yan et al., 2021) (PDB code: 7CYQ) is
shown as spheres with C atoms in green color to indicate the catalytic center of
nsp12 NiRAN. A zinc finger (ZF3) in nsp14 N7-MTase is highlighted by a black
dashed circle.
(B) The electrostatic potential surface of nsp14 in Cap(0)-RTC in views from the
side of and the opposite side where the catalytic center of nsp12 NiRAN is
located. Positively charged regions that potentially constitute pre-mRNA
transferring path are highlighted by dashed frames.
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Articleits inhibition by nucleotide analog inhibitors (e.g., remdesivir)
have been well characterized (Chen et al., 2020; Gao et al.,
2020; Wang et al., 2020; Yan et al., 2020, 2021). However, how
CCC couples in SARS-CoV-2 RTC remains unclear. Here, we
have reconstituted SARS-CoV-2 Cap(0)-RTC and determined
its structure, providing the first images for the coupling of N7-
CCC in RTC and for dissecting the mechanism of the capping
actions. In N7-CCC, the catalytic site of nsp12NiRAN, which cat-
alyzes the second capping action to yield GpppA, locates on the
opposite side of the catalytic center of nsp14 N7-MTase,
which facilitates the third capping action to generate the cap(0)
(7MeGpppA) (Figure 5A). A possible path for transferring the 50
end of pre-mRNA with GpppA is reasoned that initiating fromnsp12 NiRAN, passing through a positively charged region sur-
rounded by nsp14K433/K440/K512, and reaching the catalytic
site of nsp14 N7-MTase (Figure 5B). Notably, a zinc finger
(ZF3) has been reported at nsp14C484/C452/C477/H487 in the
crystal structure (Ma et al., 2015). This zinc finger is located on
the potential path of transferring mRNA and may play a role in
stabilizing mRNA for further modification. Moreover, A1 of
GpppA is buried in a deep pocket in nsp14 N7-MTase, but G0
of GpppA is relatively exposed to solvent in the crystal structure
(Ma et al., 2015) (Figure 5B, left panel). This conformation is not
likely to allow the connection of A1 to the downstream sequence
of mRNA, indicating the binding of the 50 end of pre-mRNA with
GpppA to the catalytic center of nsp14 N7-MTase may vary from
that observed in the crystal structure. Moreover, the potential
path for transferring mRNA on N7-CCC is occupied in dCap(0)-
RTC by another Cap(0)-RTC protomer, indicating the capping
actions may not occur in dCap(0)-RTC.
RNA viruses commonly exhibit high mutation rates, being
attributed to the relatively low replication fidelity of their RNA-
dependent RNA polymerase (RdRp) and the lack of proofreading
mechanism (Ogando et al., 2020). Therefore, the expansion of
RNA genome sizes is restricted to below 15 kb for most RNA vi-
rus families to balance replication fidelity, genome size, and
complexity (Saberi et al., 2018). CoVs have the largest RNA
genomes among RNA viruses and employ a proofreading mech-
anism to ensure replication fidelity. In proofreading, mis-incorpo-
rated nucleotides are excised through the 30-50 ExoN activity of
nsp14 (Ferron et al., 2018; Munster et al., 2020; Ogando et al.,
2019), but the concerted motion between nsp14 ExoN and poly-
merase remains unclear. In bacteria and eukaryotes, backtrack-
ing, which refers to the reversible sliding of RNA polymerase
along DNA/RNA, has been implicated inmany critical processes,
including providing a basic mechanism for transcriptional proof-
reading (Nudler, 2012; Nudler et al., 1997; Sosunov et al., 2003).
Anymis-match nucleotides in the RNA:DNA hybrid would induce
immediate backtracking, thus resulting in the subsequent
removal of the mis-incorporated nucleotides at 30 end of RNA
by exonuclease (Nudler, 2012; Wang et al., 2009). In SARS-
CoV-2 mCap(0)-RTC, the catalytic center of nsp14 ExoN is distal
from the polymerase reaction center of nsp12 and the exit of
product RNA with an approximate distance of 80 and 120 Å (Fig-
ure 6A), indicating proofreading occurring in the monomeric
Cap(0)-RTC is less likely. Interestingly, in dCap(0)-RTC, the cat-
alytic center of nsp14 ExoN of one Cap(0)-RTC protomer faces
to the polymerase reaction center of nsp12 at the 30 end of primer
chain at a distance of ~35 Å (Figure 6A). Considering the ~6 Å
average length between two nucleotides in a single-stranded
RNA, a backtracking of RNA with 6 nucleotides from the nsp12
polymerase reaction center in one Cap(0)-RTC protomer is plau-
sible to reach the catalytic center of nsp14 ExoN in another
Cap(0)-RTC protomer (Figures 6B and 6C). Based on these
structural features, we propose a speculative model for an in
trans backtracking mechanism for SARS-CoV-2 proofreading
concerted by nsp12 polymerase, nsp13-2 helicase, and nsp14
ExoN (Figure 6D). In the elongation step, nsp13-2 functions as
a helicase to unwind the high-ordered structure in the genome
with the help of nsp13-1. At this stage, nsp13-2 1B domain is
in position to constitute a RNA-binding groove together withCell 184, 3474–3485, June 24, 2021 3481
Figure 6. An in trans backtracking model for proofreading
(A) Distance between the catalytic center of nsp14 ExoN in one Cap(0)-RTC protomer with the 50 end of primer RNA in the same Cap(0)-RTC protomer and the
catalytic center of nsp12 polymerase in two Cap(0)-RTC protomers of the dimeric Cap(0)-RTC. The polypeptides of nsp14 ExoN are shown as a cartoon diagram
in pale green, whereas other polypeptides in the dimeric Cap(0)-RTC are displayed as white cartoons. The catalytic residues in the nsp14 ExoN active center are
shown as red spheres. The nucleotides at the 30 end of the modeled primer RNA is displayed as red spheres to indicate the catalytic center of nsp12 polymerase.
The nucleotide at the 50 end of the modeled primer RNA is also displayed as red spheres. The distances are indicated by arrows with labels.
(B and C) A close-up view of the machinery for in trans backtracking proofreading. In protomer A, the fingers, palm, and thumb domains of nsp12 are shown as
cartoons in blue, red, and green. The template and primer RNAs are represented in cartoon diagram and the nucleotide at the 30 end of primer is shown as colored
spheres. Other components in protomer A are displayed as a semi-transparent white molecular surface. In protomer B, nsp14 ExoN is shown as cartoon in pale
green, while other components in protomer B are shown as a molecular surface in the same colors used in Figure 1. The catalytic residues of nsp14 ExoN in
(legend continued on next page)
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Article1A/2A domains for RNA unwinding and the residue nsp13-2R178
of nsp13-2 1B locates in the position of tA+10 at the 50 end of
the unpaired template RNA as presented in E-RTC. Once RTC
senses the mis-incorporated nucleotide, nsp13-2 1B would
undergo a large conformational changes in dCap(0)-RTC, allow-
ing nsp13-2R178 to lose contact with the nucleotide at the tA+10
position in E-RTC and move to the position of tU+7 as shown
in dCap(0)-RTC to interact with the nucleotide located there.
Subsequently, nsp13-2 1B moves back to its original position,
thus dragging the template RNA toward the upstream direction.
Meanwhile, the 30 end of primer RNA with the mis-incorporated
nucleotide is backtracked by 6 nucleotides toward the upstream
of the 30 end direction. It should be noted since the backtracking
does not really occur in dCap(0)-RTC due to RNA and
experimental conditions used to reconstitute RTCs, the binding
of nsp13-2R178 of nsp13-2 1B with tA+10 in E-RTC but with
tU+7 in dCap(0)-RTC does not mean that backtracking of 4 nu-
cleotides occurs in reality. Alternatively, the ~35 Å distance
of nsp13-2R178 of nsp13-2 1B moving from its position in
Cap(0)-RTC to its position in E-RTC suggests a backtracking
of 6 nucleotides would be possible. As a consequence, the 30
end of the backtracked primer RNA with the mis-incorporated
nucleotide would recruit nsp14 ExoN in another Cap(0)-RTC pro-
tomer, for further processing of the mis-incorporated nucleotide
at the catalytic center of nsp14 ExoN. After the correction of the
mis-incorporated nucleotide, nsp13-2 1B would return to its
original position, allowing normal helicase activity to move tem-
plate RNA forward and elongate primer RNA. At this stage,
dCap(0)-RTC is likely to be released into the monomeric form.
A recent study showed SARS-CoV-2 possessing nsp14 with
the L177F, P203L, S369F, or M501I mutations has a higher
genomic mutation rate than SARS-CoV-2 with wild-type nsp14
(Takada et al., 2020). Among these, the M501I mutation occurs
in nsp14 N7-MTase, which is not associated with the enzymatic
activity of nsp14 ExoN, but it is located on the dimer interface
and thus plays a key role in stabilizing the conformation of an he-
lix in nsp14 N7-MTase and in the formation of dCap(0)-RTC. The
impact of M501 on SARS-CoV-2 mutation rate can be explained
by our proposed model. Moreover, another recent study re-
ported a SARS-CoV-2 RdRp structure with nucleotide analogs
and finds the mis-incorporated nucleotide analogs can pause
the RdRp function, allowing nsp13 to induce backtracking,
which forces the 30 end of the primer RNA out the NTP-entry
channel (Malone et al., 2021). The direction of the primer RNA
30 end out the NTP-entry channel is consistent to that observed
in the dCap(0)-RTC structure, this being toward the catalytic
center of nsp14 ExoN.
The backtracking proofreading is widely found among DNA
polymerases (Fernandez-Leiro et al., 2017; Johnson and Beese,
2004) and RNA polymerases (Cheung and Cramer, 2011; Wang
et al., 2009) in eukaryotic and prokaryotic cells. Similarities could
be found with the backtracking proofreading in SARS-CoV-2.
For example, the distance from the catalytic center of nsp14protomer B are shown as colored stick models and are highlighted by a red dashe
A channel for the backtracked primer RNA is indicated by a red dashed line with
(D) A schematic representation of an in trans backtrackingmodel for proofreading.
nucleotides in template and primer RNAs, while the green bars indicate the mis-ExoN in one protomer to the catalytic center of polymerase of
nsp12 in another protomer is 35 Å in SARS-CoV-2 dCap(0)-
RTC, and the typical distance between the active centers of
other polymerases and ExoN is 30~40 Å in the correction of
DNA mismatch (Fernandez-Leiro et al., 2017). Unique features
could be also identified in SARS-CoV-2 backtracking proof-
reading, including the conformational change of helicase 1B
domain, as well as the specific excision of 30 mismatched nucle-
otide by nsp14 ExoN but not removal of a mismatched fragment
as observed in Pol II (Nudler, 2012).
Notably, in dCap(0)-RTC, the potential transfer path for the 50
end of pre-mRNA is through the inter-protomer interface, indi-
cating that backtracking proofreading would not concurrently
occur with capping actions. This is supported by the orientation
of nsp13-2 ZBD in a ‘‘suspending’’ state, in which nsp13-2 ZBD
inserts into the paired template:primer RNA, in both mCap(0)-
RTC and in Cap(1)0-RTC as an intermediate state during
capping actions (Yan et al., 2021). In contrast, nsp13-2 ZBD
leaves the paired template-primer RNA in free state both in
dCap(0)-RTC and in E-RTC, thus allowing the active movement
of RNA in either a ‘‘backtracking’’ state or a ‘‘elongation’’ state
(Figures 4B–4E). This gives an explanation for the simultaneous
existences of monomeric and dimeric Cap(0)-RTC in solution,
representing nsp14 as a bifunctional enzyme participating in
proofreading and in capping actions.
Furthermore, the proofreading is suggested to be a factor
impacting on the inhibitory efficacy of nucleotide analog inhibi-
tors(Robson et al., 2020). For example, EIDD-1931, a cytidine
analog with broad spectrum antiviral activity against coronavi-
ruses, is the first mutagenic nucleotide analog inhibitor demon-
strating the ability to evade nsp14 ExoN proofreading (Robson
et al., 2020). This is the reason that EIDD-1931 cannot be recog-
nized and excised by nsp14 ExoN, giving an explanation to its
enhanced efficacy against SARS-CoV-2 containing resistance
mutations to remdesivir (Sheahan et al., 2020). The structure of
dCap(0)-RTC containing a primer chain with nucleotide analog
inhibitor at the 30 end is needed to provide a structural basis
for the optimization of inhibitor to achieve higher efficacy against
drug resistant variants.
In conclusion, the structure of SARS-CoV2 Cap(0)-RTC re-
ported here presents a molecular basis for co-transcriptional
modification of SARS-CoV-2 mRNA and reveals an in trans
backtracking mechanism for proofreading. These results pro-
vide new insights on the understanding of the replication and
transcription cycle of SARS-CoV-2 and a structural basis for
the optimization of antiviral inhibitors such as EIDD-1931.
Limitations of study
Although the in trans backtrackingmodel for proofreading is pro-
posed, a structure of dCap(0)-RTC with a backtracked RNA
extended from the 30 end of primer chain at the active center
of polymerase to the active center of nsp14 ExoN is needed to
warrant in further study.d circle. The boundary of the two protomers is indicated by a black dashed line.
an arrow. A view from the opposite side is shown in (C).
Triangles in brown represent nsp13 1B; blue and red bars represent the correct
matched nucleotides.
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Pérez, L., Schulz, J., Meade-White, K., Okumura, A., Callison, J., Brumbaugh,
B., et al. (2020). Respiratory disease in rhesus macaques inoculated with
SARS-CoV-2. Nature 585, 268–272.
Nudler, E. (2012). RNA polymerase backtracking in gene regulation and
genome instability. Cell 149, 1438–1445.
Nudler, E., Mustaev, A., Lukhtanov, E., and Goldfarb, A. (1997). The RNA-DNA
hybrid maintains the register of transcription by preventing backtracking of
RNA polymerase. Cell 89, 33–41.
Ogando, N.S., Ferron, F., Decroly, E., Canard, B., Posthuma, C.C., and
Snijder, E.J. (2019). The Curious Case of the Nidovirus Exoribonuclease: Its
Role in RNA Synthesis and Replication Fidelity. Front. Microbiol. 10, 1813.
Ogando, N.S., Zevenhoven-Dobbe, J.C., van der Meer, Y., Bredenbeek, P.J.,
Posthuma, C.C., and Snijder, E.J. (2020). The Enzymatic Activity of the nsp14
Exoribonuclease Is Critical for Replication of MERS-CoV and SARS-CoV-2.
J. Virol. 94, e01246, 20.
Pettersen, E.F., Goddard, T.D., Huang, C.C., Couch, G.S., Greenblatt, D.M.,
Meng, E.C., and Ferrin, T.E. (2004). UCSF Chimera–a visualization system
for exploratory research and analysis. J. Comput. Chem. 25, 1605–1612.
Punjani, A., Rubinstein, J.L., Fleet, D.J., and Brubaker, M.A. (2017). cryo-
SPARC: algorithms for rapid unsupervised cryo-EM structure determination.
Nat. Methods 14, 290–296.
Robson, F., Khan, K.S., Le, T.K., Paris, C., Demirbag, S., Barfuss, P., Rocchi,
P., and Ng, W.L. (2020). Coronavirus RNA Proofreading: Molecular Basis and
Therapeutic Targeting. Mol. Cell 80, 1136–1138.
Rohou, A., and Grigorieff, N. (2015). CTFFIND4: Fast and accurate defocus
estimation from electron micrographs. J. Struct. Biol. 192, 216–221.
Rosenthal, P.B., and Henderson, R. (2003). Optimal determination of particle
orientation, absolute hand, and contrast loss in single-particle electron cryomi-
croscopy. J. Mol. Biol. 333, 721–745.Saberi, A., Gulyaeva, A.A., Brubacher, J.L., Newmark, P.A., and Gorbalenya,
A.E. (2018). A planarian nidovirus expands the limits of RNA genome size.
PLoS Pathog. 14, e1007314.
Scheres, S.H. (2012). RELION: implementation of a Bayesian approach to
cryo-EM structure determination. J. Struct. Biol. 180, 519–530.
Shabek, N., Ticchiarelli, F., Mao, H., Hinds, T.R., Leyser, O., and Zheng, N.
(2018). Structural plasticity of D3-D14 ubiquitin ligase in strigolactone signal-
ling. Nature 563, 652–656.
Sheahan, T.P., Sims, A.C., Zhou, S., Graham, R.L., Pruijssers, A.J., Agostini,
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Data and code availability
The cryo-EM density maps and the structures were deposited into the Electron Microscopy Data Bank (EMDB) and Protein Data
Bank (PDB) with the accession numbers 31138 and 7EGQ for dCap(0)-RTC, and 31146 and 7EIZ for mCap(0)-RTC.
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Proteins were obtained through recombinant expression in E. coli BL21 (DE3).
METHOD DETAILS
Protein production and purification
The SARS-CoV-2 nsp12 (GenBank: MN908947) gene was cloned into a modified pET-22b vector, with the C terminus possessing a
10 3 His-tag. Protein was expressed in E. coli BL21 (DE3) as described(Yan et al., 2021). The cells were harvested and the pellets
were resuspended in a buffer (20 mM Tris-HCl, pH 8.0, 150 mM NaCl, 4 mM MgCl2, 10% glycerol) and homogenized with an ultra-
high-pressure cell disrupter at 4C. The insoluble material was removed by centrifugation at 14,000 rpm for 50min. The fusion protein
was first purified by Ni-NTA (Novagen, USA) affinity chromatography and then further purified by passage through a Hitrap Q ion-ex-
change column (GE Healthcare, USA) with buffer A (20 mM Tris-HCl, pH 8.0, 4 mM MgCl2, 10% glycerol, 4 mM DTT) and buffer B
(20 mM Tris-HCl, pH 8.0, 1M NaCl, 4 mM MgCl2, 10% glycerol, 4 mM DTT). Next the sample was loaded onto a Superdex 200
10/300 Increase column (GE Healthcare, USA) with DEPC-treated buffer C (50 mM HEPES, pH 7.0, 100 mM NaCl, 4 mM MgCl2,
2 mM GDP and 2 mM BeF3
-). Purified nsp12 was concentrated to 4.8 mg/mL and stored at 4C.
The SARS-CoV-2 nsp10 was cloned into pGEX-6p vector with a N-terminal GST -tag, and SARS-CoV-2 nsp14 inserted into
pRSF-duet with no tag, and co-transformed into E. coli strain BL21 (DE3). Cells were harvested by centrifugation at 4000 rpm for
10 min, and the pellets resuspended in lysis buffer (25 mM HEPES, pH7.0, 300 mM NaCl, 4 mM MgCl2, 5% glycerol). An ultra-
high-pressure cell disrupter at 4C was used for lysis,and the product was centrifuged for 14000 rpm at 4C. Recombinant pro-
tein was purified by GST-affinity chromatography and the GST-tag was removed by PreScission protease. The complex was
further purified by passage through a Hitrap SP ion-exchange column (GE Healthcare, USA) with buffer A (25 mM HEPES,
pH 7.0, 4 mM MgCl2, 10% glycerol, 4 mM DTT) and buffer B (25 mM HEPES, pH7.0, 1 M NaCl, 4 mM MgCl2, 10% glycerol,
4 mM DTT). Then it was load onto a Superdex 200 10/300 Increase column (GE Healthcare, USA) with a buffer (50 mM HEPES,
pH 7.0, 250 mM NaCl, 4 mM MgCl2, 4 mM DTT). Purified nsp10/nsp14 complex was concentrated to 8 mg/mL and stored at
4C. The nsp9-10 sample was also cloned into pGEX-6p vector, and the purification of nsp9-10/nsp14 complex was identical
to the procedure for nsp10/nsp14.The preparation of nsp9 was performed as described previously(Yan et al., 2021). Nsp9 was
cloned into a modified pET-28b-SUMO with the N terminus of a fusion of 6 3 His-tag. The protein was expressed in E. coli strain
BL21 (DE3). After harvesting by centrifugation, the pellets were resuspended in lysis buffer (20 mM HEPES, pH 7.0 and 150 mM
NaCl) and homogenized with an ultra-high-pressure cell disrupter at 4C. The lysate was centrifuged at 12,000 rpm for 30 min to
remove cell debris. The fusion protein was purified by Ni-NTA (Novagen, USA) affinity chromatography and by application to a
Superdex 200 10/300 Increase column (GE Healthcare, USA) in lysis buffer. Purified nsp9 was concentrated to 5 mg/mL and
stored at 4C.
Full-length SARS-CoV-2 nsp7 and nsp8were co-expressed in E. coliBL21 (DE3) cells as a no-tagged protein and a 63His-SUMO
fusion protein, respectively. After purification byNi-NTA (Novagen, USA) affinity chromatography, the nsp7-nsp8 complexwas eluted
through on-column tag cleavage by ULP protease. The complex was further purified by using a Hitrap Q ion-exchange column (GE
Healthcare, USA) and a Superdex 200 10/300 Increase column (GE Healthcare, USA) in buffer C containing 50 mM HEPES, pH 7.0,
100 mM NaCl, 4 mM MgCl2, 2 mM GDP and 2 mM BeF3
-.
Nsp13 was purified as described previously(Yan et al., 2021). The nsp13 gene was inserted into the modified pET-28a vector
with a 6 3 His tag attached at its N terminus, and protein was expressed in E. coli BL21 (DE3) cells. Cells were harvested and
resuspended in lysis buffer (20 mM HEPES, pH 7.0, 150 mM NaCl, 4 mM MgCl2, 10% glycerol). The cells were centrifuged at
14,000 rpm for 40 min and then lysed by high-pressure homogenization and sonication. The fusion protein was purified by Ni-
NTA (Novagen, USA) affinity chromatography and Hitrap SP ion-exchange column (GE Healthcare, USA), and finally nsp13 protein
was loaded onto a Superdex 200 10/300 Increase column (GE Healthcare, USA) in buffer C. Purified nsp13 was concentrated to
8 mg/mL and stored at 4C.Cell 184, 3474–3485.e1–e3, June 24, 2021 e2
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ArticleAssembly of the Cap(0)-RTC
Nsp12 was incubated with nsp7 and nsp8 at 4C for three hours in a molar ratio of 1: 2: 2 in buffer (50 mM HEPES, pH 7.0, 100 mM
NaCl and 4 mM MgCl2). Next, the mixture was purified by mono Q 5/50 ion-exchange chromatography (GE Healthcare, USA), pro-
ducing the nsp7-nsp8-nsp12 complex (C-RTC). C-RTC and nsp13 and RNA were mixed to form E-RTC at a 1:2:1 molar ratio as
described previously(Yan et al., 2020). E-RTC was incubated with the nsp9-nsp10/nsp14 complex at a 1:1.2 molar ratio with
2 mM GDPdBeF3
- to assemble the Cap(0)-RTC.
Native electrophoretic mobility shift assays
The binding reaction buffer contained 50 mM HEPES, pH 7.0, 100 mM NaCl, 2 mMMgCl2, 2 mM GDP and 2 mM BeF3
-. 18 mg RdRp
(nsp12-nsp7-nsp8) complex protein was combined with 1.5 mg template-primer RNA, and RdRp/RNA and nsp13, or nsp9, or nsp10/
14 mixed in a 1:2, or 1:1.2, or 1:1.2 molar ratio. Binding reactions were incubated for 30 min at 30C. Reactions were run on a six lane
polyacrylamide native gel (37.5:1 acrylamide:bis-acrylamide) running in 13 TBEbuffer at 150 V for 1h in 4C. The gel was stainedwith
ethidium bromide.
Cryo-EM sample preparation and data collection
In total, 3 mL of protein sample at 3 mg/mL (added with 0.025% DDM) was applied onto a H2/O2 glow-discharged, 200-mesh Quan-
tifoil R0.6/1.0 grid (Quantifoil, Micro Tools GmbH, Germany). The grid was then blotted for 3.0 s with a blot force of 0 at 8C and 100%
humidity and plunge-frozen in liquid ethane using a Vitrobot (Thermo Fisher Scientific, USA). Cryo-EM data were collected with a 300
keV Titan Krios electron microscope (Thermo Fisher Scientific, USA) and a K3 direct electron detector (Gatan, USA). Images were
recorded at 22500 3 magnification and calibrated at a super-resolution pixel size of 0.82 Å/pixel. The exposure time was set to
2 s with a total accumulated dose of 60 electrons per Å2. All images were automatically recorded using SerialEM. A total of
12,704 images were collected with a defocus range from 2.0 mm to 1.0 mm. Statistics for data collection and refinement are in
Table S1. The methods for processing are described in Figures S2 and S4.
Cryo-EM image processing
All dose-fractioned images were motion-corrected and dose-weighted by MotionCorr2(Zheng et al., 2017) software and their
contrast transfer functions were estimated by ctffind4(Rohou and Grigorieff, 2015). A total of 2,039,214 particles were auto-picked
using the model from SARS-CoV-2 Cap(1)’-RTC (PDB: 7CYQ)(Yan et al., 2021) and extracted with a box size of 448 pixels in cry-
oSPARC(Punjani et al., 2017). The following 2D, 3D classifications and refinements were all performed in cryoSPARC. 887,588
particles were selected after two rounds of 2D classification based on complex integrity. This particle set was used to do Ab-Initio
reconstruction in five classes, which were then used as 3D volume templates for heterogeneous refinement, with 135,801 particles
converged into dCap(0)-RTC complex class and 80,256 particles converged into mCap(0)-RTC complex class. Next, these particles
were imported into RELION 3.03(Scheres, 2012) to perform local classification to obtain one class particle with final resolution 3.35 Å
and 3.78 Å, respectively. The methods are described in Figures S2 and S4.
Model building and refinement
To build the structure of SARS-CoV-2 Cap(0)-RTC complex, we started with the model of the SARS-CoV-2 nsp12 and nsp7-8 com-
plex (PDB: 7BTF), SARS-CoV-2 nsp13 (PDB: 6ZSL), nsp9 (PDB: 6W9Q) and nsp10/nsp14 (PDB: 6C8S). These were individually
placed and rigid-body fitted into the cryo-EMmap using UCSFChimera(Pettersen et al., 2004). Themodel wasmanually built in Coo-
t(Emsley et al., 2010) with the guidance of the cryo-EM map, and with real space refinement using Phenix(Afonine et al., 2018). The
data validation statistics are shown in Table S1.
QUANTIFICATION AND STATISTICAL ANALYSIS
In Figures S2 and S4, the resolution estimations of cryo-EM density maps are based on the 0.143 Fourier Shell Correlation (FSC) cri-
terion(Chen et al., 2013; Rosenthal and Henderson, 2003).e3 Cell 184, 3474–3485.e1–e3, June 24, 2021
Supplemental figures
Figure S1. Biochemical analysis, related to Figure 1
(A) 10% SDS-PAGE analysis of the components used to constitute the RTCs. Lanes 1 and 8, markers; lane 2, nsp7/nsp8; lane 3, nsp9; lane 4, nsp12; lane 5,
nsp13; lane 6, nsp10/nsp14 complex; lane 7, nsp9-10/nsp14 complex. The gel was stained with Coomassie blue. Because nsp14 cannot be purified in the
absence of nsp10 or nsp9-nsp10, there is no sample for the individual nsp14. Themolecular weights of proteinmarkers are indicated on the left of the SDS-PAGE.
(B) Native gel electrophoretic mobility shift assay reveals the formation of the stable complex. The 6%polyacrylamide gel was visualizedwith ethidium bromide to
stain the RNA. (C) Purification of nsp10/nsp14 and nsp9-10/nsp14 complexes by size exclusion chromatography.
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Figure S2. Cryo-EM reconstruction of SARS-CoV-2 Cap(1)0-RTC incubated with nsp10/nsp14, related to Figure 1
(A) Raw image of the SARS-CoV-2 Cap(-)’-RTCwith nsp10/14 complex particles in vitreous ice recorded at defocus values of1.0 to1.8 mm. Scale bar, 50 nm.
(B) Power spectrum of the image shown in (A), with an indication of the spatial frequency corresponding to 3.0 Å resolution. (C) Representative class averages.
The edge of each square is ~367 Å in length. (D) Flowchart of SARS-CoV-2 Cap(-)’-RTCwith nsp10/14 reconstruction. Local resolution estimation is shown at the
bottom panel. (E) Fourier shell correlation (FSC) of the final 3D reconstruction following gold standard refinement. FSC curves are plotted before and after
masking. (F) Angular distribution heatmap of particles used for the refinement. (G) The 3DFSC sphericity analyzed with 3DFSC in cryoSPARC(Punjani et al., 2017)
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Figure S3. Comparison of cryo-EM densities, related to Figure 1
The cryo-EM densities of Cap(1)’-RTC (A), initial test dataset for Cap(1)’-RTC incubated with nsp10/nsp14 (B), and mCap(0)-RTC with final resolution (C) are
shown in the same orientation and threshold. The color scheme is the same as that used in Figure 1.
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(legend on next page)
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Figure S4. Cryo-EM reconstruction of SARS-CoV-2 Cap(0)-RTC, related to Figure 1
(A) Raw image of the dCap(0)-RTC and mCap(0)-RTC particles in vitreous ice recorded at defocus values of 1.0 to 1.8 mm. Scale bar, 50 nm. (B) Power
spectrum of the image shown in (A), with an indication of the spatial frequency corresponding to 3.0 Å resolution. (C) Representative class averages. The edge of
each square is ~367 Å. (D) Flowchart of SARS-CoV-2 dCap(0)-RTC and mCap(0)-RTC reconstruction. Local resolution estimation is shown at the bottom
panel.(E) Fourier shell correlation (FSC) of the final 3D reconstruction following gold standard refinement. FSC curves are plotted before and after masking. (F)
Angular distribution heatmap of particles used for the refinement. (G) The 3DFSC sphericity analyzed with 3DFSC in cryoSPARC(Punjani et al., 2017).
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Figure S5. Density and structure of Cap(0)-RTC, related to Figure 1
(A)Density of Cap(0)-RTC (Related to Figure 1). Structures of Nsp12 NiRAN, nsp9, nsp10 and nsp14 are overlaid with the cryo-EMmap of dCap(0)-RTC protomer
in the middle panel. Four parts are shown in enlarged panels. The polypeptides of Cap(0)-RTC are displayed as colored cartoons; residues in the enlarged panels
are exhibited as colored sticks; the cryo-EM densities are shown as gray mesh with the sigma value of 10. The color scheme is the same as used in Figure 1. (B)
Structure of dCap(0)-RTC (Related to Figure 1C). Structure of dCap(0)-RTC in cartoon diagrams (upper panels) and the cryo-EM densities (bottom panels) are
shown in three perpendicular views. The two-fold axis is indicated as ellipses (left and right panel) or an arrow (middle panel). The dashed lines roughly indicate the
boundary of two Cap(0)-RTC protomers in dCap(0)-RTC (C). Compared to Figure 1C, one Cap(0)-RTC protomer is shown in colored scheme, while the other
protomer is colored in white.
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(legend on next page)
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Figure S6. Structure of nsp10/nsp14 and sequence comparison, related to Figure 2
(A) The structures of nsp10/nsp14 complex in Cap(0)-RTC and in crystallo(Ma et al., 2015) (PDB code: 5C8S) are aligned. Nsp14 as it appears in the crystal
structure is colored in magenta; nsp14 in Cap(0)-RTC and nsp10 are colored as the same scheme in Figure 1. The cryo-EM density (at a sigma value of 8.5) of the
loop region spanning residues nsp14S454-nsp14D464 is shown in the right panel. (B) The alignment of nsp14 encoding by SARS-2, SARS, MERS, RaTG13. The
residues in blue, light blue, or white shading indicate the identical, conserved or non-conserved residues, respectively. The interacting residues of nsp14 are
highlighted by colored frames.
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